The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed the first RNA-based genetic switch that precisely replicates the logical ...

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center ...

An interdisciplinary research team from two working groups at the Centre for Synthetic Biology at TU Darmstadt has developed the first RNA-based genetic switch that precisely replicates the logical ...

Add Yahoo as a preferred source to see more of our stories on Google. A simulated cell in the early stages of division. Left half shows cytoplasm (blue cubes), mRNA degradation machinery molecules ...

"It's probably one of the most egregious demonstrations of government overreach imaginable." | Opinion ...

Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...

A recent study by Fred Hutch biochemist Christopher Lapointe, PhD, and his colleagues, uses innovative lab techniques to ...

Scientists have developed an AI model capable of reading, analyzing and generating genetic code across all known domains of life—a development with vast implications for understanding human disease, ...

Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 3:30 PM EDTCompany ParticipantsNicholas Keher ...